Results 301 to 310 of about 797,280 (374)
Can a One-Time Subtle Attachment Security Priming Impact Outcomes in the Real World? [PDF]
Gillath O, Liese BS, Karantzas GC.
europepmc +1 more source
Radiotherapy medical physics in the Philippines: A contemporary overview
Abstract Purpose With cancer ranking as the third leading cause of death in the Philippines and a disparity in healthcare resources across regions, this research aimed to assess the state of radiotherapy medical physics in the country. Methodology The study utilized a comprehensive online survey with 94 structured questions answered by 19 clinics ...
John Paul C. Cabahug+4 more
wiley +1 more source
Abstract Purpose Histotripsy is a focal tumor therapy that utilizes focused ultrasound (US) to mechanically destroy tissue. To overcome visualization limitations of diagnostic US‐guidance, C‐arm cone beam CT (CBCT)‐guided histotripsy is being developed, for which a mobile C‐arm could increase accessibility. CBCT‐guided histotripsy uses a phantom with a
Grace M. Minesinger+5 more
wiley +1 more source
Abstract Purpose To create and conduct a comprehensive onsite end‐to‐end dosimetry audit to assess treatment accuracy of spine, lung, and soft tissue Stereotactic Body Radiotherapy (SBRT) across Australian and New Zealand (ANZ) radiotherapy centers. Methods The Australian Clinical Dosimetry Service (ACDS) anthropomorphic thorax phantom underwent a CT ...
Maddison Shaw+8 more
wiley +1 more source
Poster presentations: Preclinical studies(II)
Sean Thomas O’Reilly+81 more
openalex +1 more source
ABSTRACT C‐truncating variants in the charged multivesicular body protein 2B (CHMP2B) gene are a rare cause of frontotemporal lobar degeneration (FTLD), previously identified only in Denmark, Belgium, and China. We report a novel CHMP2B splice‐site variant (c.35‐1G>A) associated with familial FTLD in Spain. The cases were two monozygotic male twins who
Sara Rubio‐Guerra+17 more
wiley +1 more source
Menin inhibitors from monotherapies to combination therapies: clinical trial updates from 2024 ASH annual meeting. [PDF]
Cao G, Zhang H, Sun S, Zhu HH.
europepmc +1 more source